Arcus biosciences to participate in the 6th annual evercore isi healthconx conference

Hayward, calif.--(business wire)--arcus biosciences (nyse:rcus), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, announced that its management team will participate in a fireside chat at the upcoming 6th annual evercore isi healthconx conference in miami, fl. the fireside chat will take place on tuesday, november 28th, 2023 at 7:55am et. a live webcast of the fireside chat will be available by vi.
RCUS Ratings Summary
RCUS Quant Ranking